
Illumina Inc. (NASDAQ:ILMN) has agreed to pay $9.8 million to resolve allegations it knowingly sold genomic sequencing systems with cybersecurity vulnerabilities to several U.S. government agencies.
The agreement stems from a whistleblower lawsuit filed under the False Claims Act by Erica Lenore, who will receive $1.9 million as part of the settlement.